跳至主要内容
临床试验/NCT04298580
NCT04298580Unknown不适用

Randomized, Single-Blinded Study to Evaluate the Timing Effect of Ultrasound-Guided Paravertebral Block in Patients Undergoing Robotic Mitral Valve Repair Procedure

Cedars-Sinai Medical Center0 个研究点目标入组 60 人开始时间: 2020年9月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
主要终点
Durations of ICU and hospitalization

研究概览

简要总结

This study is to evaluate whether the administration of ultrasound-guided paravertebral block (PVB) after surgery would produce better postoperative pain control and fast postoperative recovery after Robotic cardiac surgery. Half of participants will receive PVB before surgery, while the other half will receive PVB at the end of surgery.

详细描述

Ultrasound-guided PVB (either before surgery, or after surgery) is the standard postoperative pain management for Robotic cardiac surgery. This technique is to inject local anesthetic (numb medication) around nerve to decrease pain. But the optimal time of PVB is unknown.

The administration of PVB before surgery can help pain control during the surgery and after surgery. But the duration of PVB could be reduced because surgery itself can last 5-6 hrs.

The PVB after surgery will not provide pain control during surgery, but may provide longer pain control after surgery, and may help participants faster recovery after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

盲法说明

Outcomes assessor will be blinded to study group

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 yrs
  • Either gender

排除标准

  • Refusal to participate in the study
  • Age< 18 yrs
  • Contraindications to regional blockage including but not limited to:
  • Patient refusal to regional blockade
  • Infection at the site of needle insertion
  • Systemic infection
  • Bleeding diathesis or coagulopathy

结局指标

主要结局

Durations of ICU and hospitalization

时间窗: 2-6 days

Duration (days) of ICU stay, and duration of hospital stay

次要结局

  • Pain intensity measure(2-3 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Manxu Zhao

Principal Investigator

Cedars-Sinai Medical Center

相似试验